Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Update research from QuotedData

14 Feb 2023 08:44

RNS Number : 8615P
Civitas Social Housing PLC
14 February 2023
 

Civitas Social Housing - Update research from QuotedData

14th February 2023

Time to buy?

Civitas Social Housing (CSH) has suffered a sustained fall in its share price which sees it now trade on a discount of 44.4%. This seems wholly unjustified given the strong market fundamentals in the social housing sector and the group's proven, secure government-backed income.

CSH's inflation-linked leases (which benefit from annual rental uplifts in line with inflation as measured by the consumer price index (CPI) or CPI+1%) more than compensated for a higher discount rate used to value its portfolio on a discounted cash flow method (following market volatility caused by higher interest rates) and resulted in CSH reporting a healthy uplift in net asset value (NAV) in September 2022 - one of the only real estate investment trusts (REITs) to do so in the period. Its NAV fell by 3.4% in the quarter to December 2022, which compares favourably with the REIT sector.

The inflation protection, improving strength of its tenants, and strong market fundamentals make the group's discount to NAV and high dividend yield extremely attractive.

Full Research:

https://quoteddata.com/research/civitas-social-housing-time-buy-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Civitas Social Housing Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUSSWRORUUARR
Date   Source Headline
13th Feb 20194:24 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSNet Asset Values, Investment and Market Update
25th Jan 20194:39 pmRNSBespoke Supportive Tenancies: Grading Under Review
18th Jan 20193:01 pmRNSDirector/PDMR Shareholding
18th Jan 20192:59 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
14th Jan 20193:51 pmRNSHolding(s) in Company
14th Jan 20193:48 pmRNSHolding(s) in Company
2nd Jan 20194:16 pmRNSTotal Voting Rights
24th Dec 201811:45 amRNSHolding(s) in Company
21st Dec 20187:00 amRNSAcquisition
20th Dec 20185:45 pmRNSCivitas Social Housing
20th Dec 20185:29 pmRNSDirector/PDMR Shareholding
20th Dec 20181:28 pmRNSCONVERSION OF C SHARES
5th Dec 20187:00 amRNSUpdate on Westmoreland and the Company's Portfolio
5th Dec 20187:00 amRNSAcquisition
30th Nov 201810:07 amRNSAdviser's Update
29th Nov 20187:00 amRNSDividend Declaration
29th Nov 20187:00 amRNSHalf-year Report
15th Nov 20187:00 amRNSConversion of C Shares
9th Nov 20187:00 amRNSFTSE 250 Index Inclusion
8th Nov 20186:12 pmRNSWoodford Patient Capital Trust
2nd Nov 20187:00 amRNSAcquisition
1st Nov 20187:00 amRNSNet Asset Values, Investment and Market Update
31st Oct 20187:00 amRNSAcquisition
22nd Oct 20187:00 amRNSAcquisition
4th Oct 20187:00 amRNSAcquisition
20th Sep 20185:11 pmRNSHolding(s) in Company
7th Sep 201810:00 amRNSEPRA Index Inclusion
7th Sep 20187:00 amRNSAcquisition
29th Aug 20189:57 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
29th Aug 20189:35 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
28th Aug 20187:00 amRNSAcquisition
24th Aug 201812:57 pmEQSHardman & Co Research: Civitas Social Housing (CSH): Housing security
22nd Aug 201811:22 amRNS£37.6m acquisition of regulated social housing
9th Aug 201811:48 amRNSHolding(s) in Company
6th Aug 20187:00 amRNSAcquisition
3rd Aug 20187:00 amRNSNet Asset Values, Investment and Market Update
2nd Aug 20186:05 pmRNSResult of AGM
3rd Jul 20187:00 amRNSNotice of AGM
14th Jun 20188:23 amRNS£5.4 million acquisition
13th Jun 201810:04 amRNSInitiation research from QuotedData
12th Jun 20187:00 amRNSAnnual Results
12th Jun 20187:00 amRNSPublication of Independent Social Impact Report
12th Jun 20187:00 amRNS£20m increase in 3-Year Revolving Loan Facility
11th Jun 20187:00 amRNS£500 million Invested into Social Housing
11th Jun 20187:00 amRNSAcquisition
1st Jun 20187:00 amRNSAcquisition
30th May 20189:13 amRNSNet Asset Values, Investment and Market Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.